Drug Shortage Report for MAR-DILTIAZEM CD
| Report ID | 143837 |
| Drug Identification Number | 02484072 |
| Brand name | MAR-DILTIAZEM CD |
| Common or Proper name | DILTIAZEM CD |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 180MG |
| Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) |
| Route of administration | ORAL |
| Packaging size | 100 Tablet |
| ATC code | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-09-01 |
| Actual start date | 2020-09-08 |
| Estimated end date | 2021-11-15 |
| Actual end date | 2022-03-10 |
| Shortage status | Resolved |
| Updated date | 2022-07-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-07-20 | French | Compare |
| v4 | 2022-07-20 | English | Compare |
| v3 | 2021-08-10 | French | Compare |
| v2 | 2021-08-10 | English | Compare |
| v1 | 2021-08-09 | English | Compare |
Showing 1 to 5 of 5